Motion Stimulation Therapy Market Snapshot (2022 – 2032)
Motion Stimulation Therapy is a type of physical therapy that is used after an event such as a stroke or spinal cord injury causes muscle denervation, paralysis, or weakness. Motion stimulation therapy helps to produce the voluntary forces needed for joint moments, allowing for the functional performance of daily tasks.
Request a Sample Copy of this research:
Motion Stimulation Therapy Market Size was valued at US$ 1.1 Million in FY 2021, and is projected to grow at a 9.1% Y-o-Y growth rate until 2022, reaching a market value of US$ 1.2 Million. During the forecast period ranging from 2022 to 2032, a CAGR of 4.1% is expected for the market, reaching US$ 1.8 Million.
Muscle spasms, pain relief, and inflammation reduction can all benefit from motion stimulation therapy. Motion stimulation therapy also promotes muscle contraction, which aids in the prevention of muscle atrophy. Parkinson’s disease, a progressive neurodegenerative disorder that primarily affects the elderly, can benefit from motion stimulation therapy.
Base Year Value (2021)
US$ 1.1 Million
Expected Market Value (2022)
US$ 1.2 Million
Anticipated Forecast Value (2032)
US$ 1.8 Million
Projected Growth Rate (2022-2032)
Deep brain stimulation (DBS) is a type of movement stimulation therapy used to treat Parkinson’s disease. Deep brain stimulation is the most commonly used surgical treatment for Parkinson’s disease. Advanced motion stimulation therapies, such as functional stimulation and therapeutic electric stimulation, are also commonly used to improve outcomes and speed up recovery from muscular dysfunction. These therapies make use of devices that use electric impulses to electrically stimulate and contract muscles.
Which are Some Prominent Drivers Spearheading Motion stimulation therapy Market Growth?
The increasing prevalence of Parkinson’s disease is the primary factor driving the growth of the motion stimulation market. The rising number of traffic accidents and muscle injuries is expected to propel the motion stimulation therapy market forward. Motion stimulation therapy can also be used in conjunction with conventional medicine.
This is known as combination therapy, and the ability to use motion stimulation therapy as an add-on therapy is expected to drive market growth in the motion stimulation therapy market. Technological advancements in stimulator devices are also aiding in the expansion of the motion stimulation therapy market.
Because of increased government funding for the development of novel drugs, the global Motion Stimulation Therapy market is expected to grow significantly during the forecast period. Each year, nearly 60,000 people in the United States are diagnosed with Parkinson’s disease, with an estimated 10 million people worldwide living with the disease, according to the Parkinson’s Association of the Carolinas.
The functional neuromuscular stimulation therapy segment is expected to gain the most market share in the global motion stimulation therapy market due to the rising prevalence of Parkinson’s disease worldwide. Due to an increase in the number of patients seeking motion stimulation therapy, hospitals are expected to be the most dominant end-user segment.
Talk to our Analyst for Further Assistance:
How is North America Contributing to the Growth of the Motion stimulation therapy Market?
Because of rising musculoskeletal disorders and increased fitness awareness, the motion stimulation therapy market in North America is expected to grow at a CAGR of 4.8 percent during the forecast period. The World Health Organization (WHO), for example, reported in February 2021 that approximately 1.71 billion people worldwide suffer from musculoskeletal disorders.
The North American region is well-positioned to reign supreme in the global muscle stimulation devices market due to high spending on healthcare products, favourable reimbursement policies, and increased adoption among sedentary consumers.
Key Companies Profiled:
Valencia CA USA, , Cyberonics, , Medtronic, , Innovative Neurotronics Inc., , Boston Scientific Corporation, , Bioness Inc., , St. Jude Medical Inc., , Nevro Corporation
CAGR of 4.1% from 2022 to 2032
Market Value for 2022
US$ 1.2 Million
Market Value for 2032
US$ 1.8 Million
Base Year for Estimation
- Therapy Type
- End User
Valencia, CA, USA, Cyberonics, Medtronic, Innovative Neurotronics, Inc. Boston Scientific Corporation; Bioness Inc. St. Jude Medical; Inc., and Nevro Corporation are some of the key players found across the value chain of motion Stimulation therapy market. Because of the large number of participants, the market is extremely competitive.
Key Segments Covered in the Motion Stimulation Therapy Market Study
Motion Stimulation Therapy Market by Therapy Type:
- Functional Neuromuscular Motion Stimulation Therapy
- Peripheral Motion Stimulation Therapy
- Deep Brain Motion Stimulation Therapy
- Therapeutic Electrical Motion Stimulation Therapy
Motion Stimulation Therapy Market by End User:
- Motion Stimulation Therapy across Hospitals
- Motion Stimulation Therapy across Specialty Clinics
- Motion Stimulation Therapy across Other End User
Motion Stimulation Therapy Market by Region:
- North America Motion Stimulation Therapy Market
- Latin America Motion Stimulation Therapy Market
- Western Europe Motion Stimulation Therapy Market
- Eastern Europe Motion Stimulation Therapy Market
- Asia Pacific excluding China & Japan Motion Stimulation Therapy Market
- China Motion Stimulation Therapy Market
- Japan Motion Stimulation Therapy Market
- Middle East and Africa Motion Stimulation Therapy Market
Browse Complete Report@ https://www.futuremarketinsights.com/reports/motion-stimulation-therapy-market